Alonso Sanchez Maria del Dado sold $92K of NBIS

Alonso Sanchez Maria del Dado (CFO) sold 470 shares of Nebius Group N.V. (NBIS) at $196.00 on 2026-09-01.

Original reporting
SEC EDGAR · Alonso Sanchez Maria del Dado
Published Sep 2, 2026, 3:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 3:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$NBIS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

Minimal price impact expected due to small transaction size relative to market cap.

02

Market read

A routine insider sale with limited relevance for traders.

03

What to watch

Small insider sales often have limited market impact.

Relevance 3/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses CFO Alonso Sanchez Maria del Dado sold 470 shares of Nebius Group N.V. for $92,120.

Market effects

none

none

none

Counterpoint

The CFO's sale may be routine and not indicative of company outlook.

Key entities

  • Nebius Group N.V.

    Issuer of the shares sold in the Form 4 filing.

  • Alonso Sanchez Maria del Dado

    CFO of Nebius Group N.V. who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.